Vertex Pharmaceuticals: Clinical Data Supports A Favorable Long-Term Growth OutlookSeeking Alpha • 09/19/22
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarinInvestors Business Daily • 09/15/22
Fed Could Boost Stocks On Sub 8% Inflation: Buy Vertex Pharmaceuticals, Sell PelotonForbes • 09/12/22
Vertex Announces U.S. FDA Approval for ORKAMBI® (lumacaftor/ivacaftor) in Children With Cystic Fibrosis Ages 12 toBusiness Wire • 09/02/22
Vertex to Participate in the Wells Fargo Healthcare Conference on Friday, September 9Business Wire • 08/31/22
Are We in a New Bull Market or a Bear Market Bounce? Here's What History ShowsThe Motley Fool • 08/29/22